Medical Properties Trust, Inc. (NYSE:MPW) Q2 2023 Earnings Conference Call August 8, 2023 11:00 AM ET
Company Participants
Charles Lambert - Vice President
Edward Aldag - Chairman, President and CEO
Steven Hamner - Executive Vice President and CFO
Conference Call Participants
Joshua Dennerlein - Bank of America
Austin Wurschmidt - KeyBanc Capital Markets
Steven Valiquette - Barclays
Vikram Malhotra - Mizuho
Mike Mueller - JPMorgan
Connor Siversky - Wells Fargo
Jonathan Hughes - Raymond James
Operator
Good day. And welcome to the Medical Properties Q2 2023 Trust Earnings Conference Call. All participants will be in a listen-only mode for the 60-minute call. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions]
Phone note, this event is being recorded. I would now like to turn the conference over to Charles Lambert, Vice President. Please go ahead.
Charles Lambert
Good morning. Welcome to the Medical Properties Trust conference call to discuss our second quarter 2023 financial results. With me today are Edward K. Aldag, Jr., Chairman, President and Chief Executive Officer of the company; and Steven Hamner, Executive Vice President and Chief Financial Officer.
Our press release was distributed this morning and furnished on Form 8-K with the Securities and Exchange Commission. If you did not receive a copy, it is available on our website at medicalpropertiestrust.com in the Investor Relations section. Additionally, we’re hosting a live webcast of today’s call, which you can access in that same section.
During the course of this call, we will make projections and certain other statements that may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause our financial results and future events to differ materially from those expressed and/or underlying such forward-looking statements.
We refer you to the company’s reports filed with the Securities and Exchange Commission for a discussion of the factors that could cause the company’s actual results or future events to differ materially from those expressed in this call. The information being provided today is as of this date only and except as required by the federal securities laws, the company does not undertake a duty to update any such information.
In addition, during the course of the conference call, we will describe certain non-GAAP financial measures, which should be considered in addition to and not in lieu of comparable GAAP financial measures.